These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 10938049)

  • 21. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
    Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).
    Clarke P; Gray A; Legood R; Briggs A; Holman R
    Diabet Med; 2003 Jun; 20(6):442-50. PubMed ID: 12786677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort.
    Laxy M; Schöning VM; Kurz C; Holle R; Peters A; Meisinger C; Rathmann W; Mühlenbruch K; Kähm K
    Pharmacoeconomics; 2019 Dec; 37(12):1485-1494. PubMed ID: 31350720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. More Versus Less Intensive Blood Pressure-Lowering Strategy: Cumulative Evidence and Trial Sequential Analysis.
    Verdecchia P; Angeli F; Gentile G; Reboldi G
    Hypertension; 2016 Sep; 68(3):642-53. PubMed ID: 27456518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
    Dormandy JA; Charbonnel B; Eckland DJ; Erdmann E; Massi-Benedetti M; Moules IK; Skene AM; Tan MH; Lefèbvre PJ; Murray GD; Standl E; Wilcox RG; Wilhelmsen L; Betteridge J; Birkeland K; Golay A; Heine RJ; Korányi L; Laakso M; Mokán M; Norkus A; Pirags V; Podar T; Scheen A; Scherbaum W; Schernthaner G; Schmitz O; Skrha J; Smith U; Taton J;
    Lancet; 2005 Oct; 366(9493):1279-89. PubMed ID: 16214598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
    Estacio RO; Jeffers BW; Hiatt WR; Biggerstaff SL; Gifford N; Schrier RW
    N Engl J Med; 1998 Mar; 338(10):645-52. PubMed ID: 9486993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Systolic and Diastolic Blood Pressure on Cardiovascular Outcomes.
    Flint AC; Conell C; Ren X; Banki NM; Chan SL; Rao VA; Melles RB; Bhatt DL
    N Engl J Med; 2019 Jul; 381(3):243-251. PubMed ID: 31314968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of antihypertensive therapy in reducing vascular complications of type 2 diabetes. Findings from the DIabetic REtinopathy Candesartan Trials-Protect 2 study.
    Tillin T; Orchard T; Malm A; Fuller J; Chaturvedi N
    J Hypertens; 2011 Jul; 29(7):1457-62. PubMed ID: 21602709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.
    McMullan CJ; Lambers Heerspink HJ; Parving HH; Dwyer JP; Forman JP; de Zeeuw D
    Am J Kidney Dis; 2014 Nov; 64(5):714-22. PubMed ID: 25064674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine.
    Tanaka S; Tanaka S; Iimuro S; Yamashita H; Katayama S; Akanuma Y; Yamada N; Araki A; Ito H; Sone H; Ohashi Y; ;
    Diabetes Care; 2013 May; 36(5):1193-9. PubMed ID: 23404305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83).
    Davis TM; Coleman RL; Holman RR;
    Diabet Med; 2014 Feb; 31(2):200-7. PubMed ID: 24267048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body mass index in early and middle adult life: prospective associations with myocardial infarction, stroke and diabetes over a 30-year period: the British Regional Heart Study.
    Owen CG; Kapetanakis VV; Rudnicka AR; Wathern AK; Lennon L; Papacosta O; Cook DG; Wannamethee SG; Whincup PH
    BMJ Open; 2015 Sep; 5(9):e008105. PubMed ID: 26373398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).
    Martin S; Schramm W; Schneider B; Neeser K; Weber C; Lodwig V; Heinemann L; Scherbaum WA; Kolb H
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):495-501. PubMed ID: 17853332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex difference in the incidence of microvascular complications in patients with type 2 diabetes mellitus: a prospective cohort study.
    Singh SS; Roeters-van Lennep JE; Lemmers RFH; van Herpt TTW; Lieverse AG; Sijbrands EJG; van Hoek M
    Acta Diabetol; 2020 Jun; 57(6):725-732. PubMed ID: 32025877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):132-44. PubMed ID: 23181634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart failure in patients with diabetes undergoing primary percutaneous coronary intervention.
    Massalha S; Luria L; Kerner A; Roguin A; Abergel E; Hammerman H; Boulos M; Dragu R; Kapeliovich MR; Beyar R; Nikolsky E; Aronson D
    Eur Heart J Acute Cardiovasc Care; 2016 Oct; 5(6):455-462. PubMed ID: 26228449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20 year follow up of a London cohort of a multinational study.
    Chaturvedi N; Jarrett J; Morrish N; Keen H; Fuller JH
    BMJ; 1996 Oct; 313(7061):848-52. PubMed ID: 8870570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.